KW-2246

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KW-2246, covering 2012-08-31 to 2020-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients [Phase 3]